NCT02344563View on ClinicalTrials.gov

Bioequivalence of Two Formulations of Meropenem Intravenous Injection

PHASE4CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions

Healthy

Interventions

DRUG

Meropem

DRUG

Mepem

All Listed Sponsors

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT02344563 - Bioequivalence of Two Formulations of Meropenem Intravenous Injection | Biotech Hunter | Biotech Hunter